Global Point-of-Care Diagnostic Devices and Equipment Market Report 2022: Market Expected to Reach $51.73 Billion by 2026 at a CAGR of 15.8% – Forecast to 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “Global Point-of-Care Diagnostics Devices And Equipment Market Report 2022” has been added to from ResearchAndMarkets.com offer.

The global point-of-care diagnostic devices and equipment market is expected to grow from USD 24.44 billion in 2021 to USD 28.74 billion in 2022 at a compound annual growth rate (CAGR) of 17.6%. The market is expected to reach $51.73 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%.

Key players in the point-of-care diagnostic devices and equipment market include Abbott, F. Hoffmann-La Roche, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, QIAGEN NV, Johnson & Johnson, Alere Inc and BioMérieux.

The point-of-care diagnostic devices and equipment market includes sales of point-of-care (POC) diagnostic devices and equipment and related services. Point-of-care diagnostic devices and equipment are designed to help physicians perform medical diagnostic tests at or near the point-of-care for immediate knowledge of diseases or conditions.

The main types of point-of-care diagnostic devices and equipment are infectious disease test kits, cardiometabolic monitoring kits, cholesterol test kits, pregnancy and fertility test kits, markers tumour/cancer, urinalysis test kits, hematology test kits, drug tests. kits, faecal occult test kits and the like.

Pregnancy and fertility test kits in point-of-care diagnostic devices are the devices used to test pregnancy and fertility in advance before going to the doctor. The different modes of prescription include prescription-based test devices and over-the-counter (OTC) test devices. These are used by end users such as professional diagnostic centers, hospitals/critical care centers, ambulatory care facilities, outpatient care facilities, research laboratories and homes.

North America was the largest region in the point-of-care diagnostic devices and equipment market in 2021. Asia-Pacific was the second largest region in the point-of-care diagnostic devices and equipment market. Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

An increase in the incidence of target diseases is driving the global POC devices and equipment market. The growing incidence of chronic diseases, such as diabetes, rheumatism or cancer, is steadily increasing across the world due to poor lifestyle choices and rise in obesity, thus driving the growth of the market for POC devices and equipment. For example, according to the Centers for Disease Control and Prevention, 2019, heart disease is also the leading cause of death in the United States, causing approximately 647,000 deaths per year.

The POC diagnostic devices and equipment market is expected to slow due to stringent regulatory policies, which increase the gestation period before the product enters the market. Manufacturers of POC devices and equipment are required to obtain several FDA clearances before launching their product on the market. The whole approval process takes a long time, thus hampering the growth of the market.

Over-the-counter (OTC) testing is considered an important trend driving the growth of the point-of-care diagnostics market. FDA approved OTC test kits for cholesterol, fecal occult blood, pregnancy, and HIV/HCV. This method would improve access to testing and early detection of the disease. These test kits may generate more revenue than prescription tests over the forecast period due to the ease of use of the kits, increased home care and self-testing, and a increased availability and adoption rate.

Main topics covered:

1. Summary

2. Features of the Point-of-Care Diagnostic Devices and Equipment Market

3. Point-of-Care Diagnostic Devices and Equipment Market Trends and Strategies

4. Impact of COVID-19 on point-of-care diagnostic devices and equipment

5. Point-of-Care Diagnostic Devices and Equipment Market Size and Growth

5.1. Global historic point-of-care diagnostic devices and equipment market, 2016-2021, in USD billion

5.1.1. Market Drivers

5.1.2. Market Constraints

5.2. Global Point-of-Care Diagnostic Devices and Equipment Market Forecast, 2021-2026F, 2031F, USD Billion

5.2.1. Market Drivers

5.2.2. Market Constraints

6. Point-of-Care Diagnostic Devices and Equipment Market Segmentation

6.1. Global Point-of-Care Diagnostic Devices and Equipment Market, Segmentation by Type, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, Billion USD

  • Infectious Disease Testing Kits

  • Cardio-Metabolic Monitoring Kits

  • Cholesterol test kits

  • Pregnancy and Fertility Test Kits

  • Tumor/cancer markers

  • Urinalysis Test Kits

  • Hematology test kits

  • Drug testing kits

  • Fecal Occult Test Kits

  • Other types

6.2. Global Point-of-Care Diagnostic Devices and Equipment Market, Segmentation by End User, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, Billion USD

  • Professional diagnostic centers

  • Hospitals/intensive care centers

  • Outpatient health care

  • Ambulatory care settings

  • Research laboratories

  • Residence

6.3. Global Point-of-Care Diagnostic Devices and Equipment Market, Segmentation by Prescription Mode, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

  • Prescription-Based Test Devices

  • Over-the-counter (OTC) test devices

7. Regional and Country Analysis of the Point-of-Care Diagnostic Devices and Equipment Market

7.1. Global Point-of-Care Diagnostic Devices and Equipment Market, Split by Region, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

7.2. Global Point-of-Care Diagnostic Devices and Equipment Market, Split by Country, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

Companies cited

  • Abbott

  • F. Hoffmann-La Roche

  • Siemens Healthineers

  • Danaher

  • Coulter Beckman

  • Becton

  • Dickinson and company

  • QIAGEN AG

  • Johnson & Johnson

  • Alère inc.

  • BioMerieux

  • Chembio Diagnostic Systems Inc.

  • EKF diagnosis

  • Trinity Biotech plc.

  • OraSure Technologies Inc.

  • Sysmex Company

  • Quidel Company

  • ApS Medical Radiometer

  • Response Biomedical Society

  • Trinity Biotech plc.

  • Bio-Rad Laboratories Inc.

  • Illuminated

  • Thermo Fisher Scientific Inc.

  • Labcorp.

  • Luminex Corporation

  • LifeScan

  • Nova

  • Diagnosis Sekisui

  • Hemocue AB

  • Akers Biosciences Inc.

For more information about this report visit https://www.researchandmarkets.com/r/8sm6rg

About Bradley J. Bridges

Check Also

Medical Matters Weekly welcomes the president of the American Academy of Family Physicians

Vermont Business Magazine Ada D. Stewart, MD, FAAFP, is the chair of the board of …